Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD

Kidney International

Volumn 51, Issue 1, 1997, Pages 182-186

  Nakayama, Masaaki ^a   Kawaguchi, Yoshindo ^b   Yamada, Kenichi ^b   Hasegawa, Toshio ^b   Takazoe, Kazunori ^b   Katoh, Naohiko ^b   Hayakawa, Hiroshi ^b   Osaka, Naoyuki ^b   Yamamoto, Hiroyasu ^b   Ogawa, Aiichiro ^b   Kubo, Hitoshi ^b   Shigematsu, Takashi ^b   Sakai, Osamu ^b   Horiuchi, Seikou ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; GLYCOSYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOPHYSIOLOGY; PERITONEUM; PRIORITY JOURNAL;

EID: 8044240930     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.22     Document Type: Article

References (15)

1. MOSNIER VM, KOHN RR, CERAMI A: Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 81:583-587, 1984
2. TSILBARY EC, CHARONIS AS, REGER LA, WOHLHUETER RM, FURCHT LT: The effect of nonenzymatic glycosylation on the binding of the main noncollagenous NC1 domain to type IV collagen. J Biol Chem 263:4302-4308, 1988
3. CHARONIS AS, REGER LA, DEGE JE, KOUZU-KOLIAKOS K, FURCHT LT, WOHLHUETER RM, TSILIBARG EC: Laminin alterations after in vitro nonenzymatic glycosylation. Diabetes 39:807-814, 1990
4. VLASSARA H, BROWNLEE M, MANOGUE KR, DINARELLO C, PASAGIAN A: Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science 240:1546-1548, 1988
5. ESPOSITO C, GERLACH H, BRETT J, STERN D, VLASSARA H: Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170:1387-1407, 1989
6. FRIEDLANDER MA, WU YC, MONNIER VM: Kinetics of formation of advanced glycosylation end products (AGEs) in peritoneal dialysis (PD). (abstract) J Am Soc Nephrol 5:447, 1994
7. YAMADA K, MIYAHARA Y, HAMAGUCHI K, NAKAYAMA M, NAKANO H, NOZAKI O, MIURA Y, SUZUKI S, TUCHIDA H, MIMURA N, ARAKI N, HORIUCHI S: Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure. Clin Nephrol 42:354-361, 1994
8. HORIUCHI S, ARAKI N, MORINO Y: Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. J Biol Chem 266:7329-7332, 1991
9. MAKITA Z, RADOFF S, RAYFIELD E: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325: 836-842, 1991
10. MAKITA Z, BUCALA R, RAYFIELD EJ, FRIEDMAN EA, KAUFMAN AM, KOBERT SM, BARTH RH, WINSTON JA, FUH H, MANOGUE K, CERAMI A, VLASSARA H: Diabetic-uremic serum advanced glycosylation end-products are chemically reactive and resistant to dialysis therapy: Role in mortality of uremia. Lancet 343:1519-1522, 1994
11. KORBET SM, MAKITA Z, FIRANEK CA, VLASSARA H: Advanced glycosylation end products in continuous ambulatory peritoneal dialysis patients. Am J Kid Dis 22:588-591, 1993
12. PAPANASTASIOU P, GRASS L, RODELA H, PATRIKAREA A, OREOPOULOS D, DIAMANDIS EP: Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int 46:216-222, 1994
13. TOPLEY N, MACKENZIE R, JORRES A, COLES GA, DAVIES M, WILLIAMS JD: Cytokine networks in continuous ambulatory peritoneal dialysis: Interactions of resident cells during inflammation in the peritoneal cavity. Perit Dial Int 13(Suppl 2):S282-S285, 1993
14. BROWNLEE M, VLASSARA H, KOONEY T, ULRICH P, CERAMI A: Aminoguanidine prevents diabetes-induced arterial wall protein crosslinking. Science 232:1629-1632, 1986
15. PANNEKEET MM, STRUIJK DK, KREDIET RT: Improvement of transcellular water transport by treatment with glucose-free dialysate in patients with ultrafiltration failure. (abstract) Perit Dial Int 16(Suppl 2):8, 1996